Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619918 · ClinicalTrials.gov registry record · Phase 2
Nebulized Hypertonic Saline for Bronchiolitis
A Phase 2 study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 447
- Enrollment target
NCT00619918: Completed Phase 2 study, sponsored by Children's Hospital Los Angeles.
NCT00619918 is a Phase 2 study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 447 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (236% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00619918, a Phase 2 study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 447 participants
- Enrollment target
Study Summary
This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.
Primary Outcome
Patients enrolled in the ED who required inpatient admission. Patients who required admission but were transferred to another facility due to lack of available beds were considered admitted for this outcome. Note, neither study site has an observation unit.
Interventions
- DRUG Nebulized 3% saline
- DRUG Nebulized 0.9% saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2008-02 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
What the finished NCT00619918 record still lists
NCT00619918 is an interventional study that assigns participants to a tested intervention. The registered 447 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (236% higher).
The record links to 0 conditions, and to 2 interventions - of which Nebulized 3% saline is the first listed.
NCT00619918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00619918 about?
NCT00619918 is a clinical study titled "Nebulized Hypertonic Saline for Bronchiolitis". This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.
What is the current status of trial NCT00619918?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 447 participants. The study started on 2008-02. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00619918?
The interventions under investigation include: Nebulized 3% saline (DRUG), Nebulized 0.9% saline (DRUG).
Who is sponsoring clinical trial NCT00619918?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00619918's enrollment target sits among peer trials
447 89th of 2000 higher than 1,912 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia